41 related articles for article (PubMed ID: 20955391)
1. Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.
Trovik J; Wik E; Stefansson I; Carter SL; Beroukhim R; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Histopathology; 2010 Oct; 57(4):641-6. PubMed ID: 20955391
[No Abstract] [Full Text] [Related]
2. High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.
Wik E; Birkeland E; Trovik J; Werner HM; Hoivik EA; Mjos S; Krakstad C; Kusonmano K; Mauland K; Stefansson IM; Holst F; Petersen K; Oyan AM; Simon R; Kalland KH; Ricketts W; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 May; 19(9):2331-41. PubMed ID: 23538402
[TBL] [Abstract][Full Text] [Related]
3. Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.
Castellvi J; Garcia A; Ruiz-Marcellan C; Hernández-Losa J; Peg V; Salcedo M; Gil-Moreno A; Ramon y Cajal S
Hum Pathol; 2009 Oct; 40(10):1418-26. PubMed ID: 19428047
[TBL] [Abstract][Full Text] [Related]
4. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
5. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Hum Pathol; 2006 Aug; 37(8):1022-31. PubMed ID: 16867865
[TBL] [Abstract][Full Text] [Related]
6. Lack of estrogen receptor-α is associated with epithelial-mesenchymal transition and PI3K alterations in endometrial carcinoma.
Wik E; Ræder MB; Krakstad C; Trovik J; Birkeland E; Hoivik EA; Mjos S; Werner HM; Mannelqvist M; Stefansson IM; Oyan AM; Kalland KH; Akslen LA; Salvesen HB
Clin Cancer Res; 2013 Mar; 19(5):1094-105. PubMed ID: 23319822
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A
Clin Cancer Res; 2008 May; 14(9):2673-80. PubMed ID: 18451231
[TBL] [Abstract][Full Text] [Related]
8. Current overview of the role of Akt in cancer studies via applied immunohistochemistry.
Shtilbans V; Wu M; Burstein DE
Ann Diagn Pathol; 2008 Apr; 12(2):153-60. PubMed ID: 18325479
[TBL] [Abstract][Full Text] [Related]
9. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
10. Maspin expression is up-regulated during the progression of endometrioid endometrial carcinoma.
Tsuji T; Umekita Y; Ohi Y; Kamio M; Douchi T; Yoshida H
Histopathology; 2007 Dec; 51(6):871-4. PubMed ID: 18042077
[No Abstract] [Full Text] [Related]
11. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
12. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
[TBL] [Abstract][Full Text] [Related]
13. PDGF-alpha and PDGF-beta are expressed in endometrial stromal sarcoma: a potential therapeutic target for tyrosine kinase inhibitors?
Liegl B; Reich O; Nogales FF; Regauer S
Histopathology; 2006 Nov; 49(5):545-6. PubMed ID: 17064305
[No Abstract] [Full Text] [Related]
14. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB.
Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L
Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479
[TBL] [Abstract][Full Text] [Related]
15. Identification of survival-related genes of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma multiforme.
Ruano Y; Mollejo M; Camacho FI; Rodríguez de Lope A; Fiaño C; Ribalta T; Martínez P; Hernández-Moneo JL; Meléndez B
Cancer; 2008 Apr; 112(7):1575-84. PubMed ID: 18260157
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of Akt, phospho-Akt and BAD expression in primary breast cancer.
Al-Bazz YO; Underwood JC; Brown BL; Dobson PR
Eur J Cancer; 2009 Mar; 45(4):694-704. PubMed ID: 19138840
[TBL] [Abstract][Full Text] [Related]
17. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
18. [Cellular polyploidy in hepatic tissue: new role of insulin].
Celton-Morizur S; Desdouets C
Med Sci (Paris); 2009; 25(6-7):651-3. PubMed ID: 19602366
[No Abstract] [Full Text] [Related]
19. AKT-driven phospho-patterns of pluripotency.
Schaefer T; Lengerke C
Cell Cycle; 2015; 14(24):3784-5. PubMed ID: 26697835
[No Abstract] [Full Text] [Related]
20. Stathmin 1: a protein with many tasks. New biomarker and potential target in cancer.
Nemunaitis J
Expert Opin Ther Targets; 2012 Jul; 16(7):631-4. PubMed ID: 22686589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
